 Check-Cap Ltd. the Company or Check-Cap NASDAQ: CHEK NASDAQ: CHEKW, NASDAQ: CHEKZ, a clinical stage medical diagnostics company advancing the development of the C-Scan System, the first and only preparation-free ingestible scanning capsule based system for the prevention of colorectal cancer through the detection of precancerous polyps, today announced positive results from the Companys pilot study of the C-Scan System in the U.S. 